TRIPHENYL CALCILYTIC COMPOUNDS FOR THE TREATMENT OF AUTOSOMAL DOMINANT HYPOCALCEMIA TYPE 1 (ADH1) von BRUCE, Simon, HARTLEY, Iris, R, FOX, Jonathan, SANI-GROSSO, Ramei, ROBERTS, Mary Scott, KOMEYLI, Ali, SRIDHAR, Ananth, COLLINS, Michael, T, GAFNI, Rachel, I, POZO, Karen, A, ROSZKO, Kelly, B. L

Volltext bestellen

TRIPHENYL CALCILYTIC COMPOUNDS FOR THE TREATMENT OF AUTOSOMAL DOMINANT HYPOCALCEMIA TYPE 1 (ADH1) von SRIDHAR, ANANTH, BRUCE, SIMON, COLLINS, MICHAEL T, POZO, KAREN A, ROSZKO, KELLY B. L, HARTLEY, IRIS R, FOX, JONATHAN, GAFNI, RACHEL I, ROBERTS, MARY SCOTT, KOMEYLI, ALI, SANI-GROSSO, RAMEI

Volltext bestellen

상염색체 우성 저칼슘혈증 타입 1(ADH1)의 치료를 위한 트리페닐 칼시라이틱 화합물 von FOX JONATHAN, KOMEYLI ALI, COLLINS MICHAEL T, ROBERTS MARY SCOTT, POZO KAREN A, SANI GROSSO RAMEI, SRIDHAR ANANTH, HARTLEY IRIS R, GAFNI RACHEL I, ROSZKO KELLY B. L, BRUCE SIMON

Volltext bestellen

Determination of FGF23 Levels for the Diagnosis of FGF23‐Mediated Hypophosphatemia von Hartley, Iris R., Gafni, Rachel I., Roszko, Kelly L., Brown, Sydney M., Castro, Luis F., Saikali, Amanda, Ferreira, Carlos R., Gahl, William A., Pacak, Karel, Blau, Jenny E., Boyce, Alison M., Salusky, Isidro B., Collins, Michael T., Florenzano, Pablo

Volltext

Hyperphosphatemic Tumoral Calcinosis: Pathogenesis, Clinical Presentation, and Challenges in Management von Boyce, Alison M, Lee, Alisa E, Roszko, Kelly L, Gafni, Rachel I

Volltext

Approach to patients with hypophosphataemia von Florenzano, Pablo, Cipriani, Cristiana, Roszko, Kelly L, Fukumoto, Seiji, Collins, Michael T, Minisola, Salvatore, Pepe, Jessica

Volltext

Identification of GNAS Variants in Circulating Cell‐Free DNA from Patients with Fibrous Dysplasia/McCune Albright Syndrome von Roszko, Kelly L., Guthrie, Lori, Li, Xiaobai, Collins, Michael T., Castro, Luis F., Boyce, Alison M.

Volltext

Tumor-Induced Osteomalacia von Florenzano, Pablo, Hartley, Iris R., Jimenez, Macarena, Roszko, Kelly, Gafni, Rachel I., Collins, Michael T.

Volltext

Hypoparathyroidism: Genetics and Diagnosis von Mannstadt, Michael, Cianferotti, Luisella, Gafni, Rachel I, Giusti, Francesca, Kemp, Elizabeth Helen, Koch, Christian A, Roszko, Kelly L, Yao, Liam, Guyatt, Gordon H, Thakker, Rajesh V, Xia, Weibo, Brandi, Maria‐Luisa

Volltext

Autosomal Dominant Hypocalcemia Type 1: A Systematic Review von Roszko, Kelly L, Stapleton Smith, Lyndsay M, Sridhar, Ananth V, Roberts, Mary Scott, Hartley, Iris R, Gafni, Rachel I, Collins, Michael T, Fox, Jonathan C, Nemeth, Edward F

Volltext

Targeted FGFR Blockade for the Treatment of Tumor-Induced Osteomalacia von Hartley, Iris R, Miller, Carole B, Papadakis, Georgios Z, Bergwitz, Clemens, Del Rivero, Jaydira, Blau, Jenny E, Florenzano, Pablo, Berglund, Jason A, Tassone, Jing, Roszko, Kelly L, Moran, Susan, Gafni, Rachel I, Isaacs, Randi, Collins, Michael T

Volltext

Efficacy and Safety of Encaleret in Autosomal Dominant Hypocalcemia Type 1 von Gafni, Rachel I., Hartley, Iris R., Roszko, Kelly L., Nemeth, Edward F., Pozo, Karen A., Lombardi, Ed, Sridhar, Ananth V., Roberts, Mary S., Fox, Jonathan C., Collins, Michael T.

Volltext

When Low Bone Mineral Density and Fractures Is Not Osteoporosis von Jha, Smita, Chapman, Marquis, Roszko, Kelly

Volltext

Mosaic Effects of Growth Hormone on Fibrous Dysplasia of Bone von Roszko, Kelly L, Collins, Michael T, Boyce, Alison M

Volltext

PTH 1‐34 Replacement Therapy Has Minimal Effect on Quality of Life in Patients With Hypoparathyroidism von Roszko, Kelly L., Hu, Tiffany Y., Guthrie, Lori C., Brillante, Beth A., Smith, Michaele, Collins, Michael T., Gafni, Rachel I.

Volltext

Genotype-Phenotype Correlation in Fibrous Dysplasia/McCune-Albright Syndrome von Zhadina, Maria, Roszko, Kelly L, Geels, Raya E S, de Castro, Luis F, Collins, Michael T, Boyce, Alison M

Volltext

Ocular Adverse Effects of Infigratinib, a New Fibroblast Growth Factor Receptor Tyrosine Kinase Inhibitor von Magone, M. Teresa, Hartley, Iris R., Fitzgibbon, Edmond, Bishop, Rachel, Arango, Mike, Moran, Susan, Vold, Roo, Rivero, Jaydira del, Pozo, Karen, Streit, Jamie, Roszko, Kelly L., Collins, Michael T., Gafni, Rachel I.

Volltext

Transcriptomic Signature and Pro-Osteoclastic Secreted Factors of Abnormal Bone-Marrow Stromal Cells in Fibrous Dysplasia von Michel, Zachary, Raborn, Layne N, Spencer, Tiahna, Pan, Kristen S, Martin, Daniel, Roszko, Kelly L, Wang, Yan, Robey, Pamela G, Collins, Michael T, Boyce, Alison M, de Castro, Luis Fernandez

Volltext

Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor‐Induced Osteomalacia von Hartley, Iris R., Roszko, Kelly L., Li, Xiaobai, Pozo, Karen, Streit, Jamie, Rivero, Jaydira, Magone, M. Teresa, Smith, Michaele R., Vold, Roo, Dambkowski, Carl L., Collins, Michael T., Gafni, Rachel I.

Volltext

C‐Terminal, but Not Intact, FGF23 and EPO Are Strongly Correlatively Elevated in Patients With Gain‐of‐Function Mutations in HIF2A: Clinical Evidence for EPO Regulating FGF23 von Roszko, Kelly Lauter, Brown, Sydney, Pang, Ying, Huynh, Thanh, Zhuang, Zhengping, Pacak, Karel, Collins, Michael T

Volltext